The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats

Calcif Tissue Int. 2020 Feb;106(2):147-157. doi: 10.1007/s00223-019-00613-1. Epub 2019 Sep 17.


Non-steroidal selective androgen receptor modulators, including ostarine, have been developed as an alternative to steroidal hormones. Ostarine has shown a beneficial effect on bone in experimental studies, but no data regarding the effect of ostarine on bone healing have yet been reported. We investigated effects of ostarine on bone healing in ovariectomized rats. Sprague-Dawley rats (3 months old) were ovariectomized (Ovx, n = 46) or left intact (Non-Ovx, n = 10). After 8 weeks, an osteotomy of the tibia metaphysis was created in all rats, and the Ovx rats were divided into four groups: untreated Ovx (n = 10) and three Ovx groups (each of 12 rats) treated with ostarine at doses of 0.04, 0.4, or 4 mg/kg BW (OS-0.04, OS-0.4, and OS-4 groups). Five weeks later, bone healing was analyzed. The OS-4 dose enhanced callus formation, increased callus density, accelerated bridging time of the osteotomy, and elevated alkaline phosphatase gene expression in callus and its protein expression in serum. In the Ovx group, most of the callus parameters were diminished. All OS treatments increased the weight of the gastrocnemius muscle, but only partly enhanced uterus weight in OS-0.4 and OS-4. Serum cholesterol level was reduced, and serum phosphorus was elevated in OS-0.04 and OS-4. Ostarine appeared to have a positive effect on early bone healing in ovariectomized rats. Considering its favorable effect on non-osteotomized bone and muscle, this treatment could be further explored as a therapy for osteoporosis. However, possible metabolic side effects should first be evaluated.

Keywords: Bone healing; Enobosarm, ovariectomy; Ostarine; Rat model; Selective androgen receptor modulator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anilides / pharmacology*
  • Anilides / therapeutic use
  • Animals
  • Bone Density / drug effects
  • Bone Density Conservation Agents / pharmacology
  • Bone Density Conservation Agents / therapeutic use
  • Disease Models, Animal
  • Estradiol / deficiency*
  • Female
  • Fracture Healing / drug effects*
  • Osteoporosis / diagnosis
  • Osteoporosis / drug therapy
  • Osteoporosis / metabolism
  • Osteoporosis / pathology
  • Ovariectomy
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Androgen / drug effects
  • Receptors, Androgen / metabolism
  • X-Ray Microtomography


  • Anilides
  • Bone Density Conservation Agents
  • Receptors, Androgen
  • Estradiol
  • ostarine